Why the study?
Heart failure causes considerable morbidity, mortality, and healthcare expenditure, with many advances emerging in the last decade requiring a concise evidence overview for clinical decision-making.
Design
Narrative review
Key result
Recent advancements in heart failure management, including SGLT-2 inhibitors, novel medical devices, and artificial intelligence, have expanded therapeutic options and improved patient outcomes.
Authors
Loading...
May inform HF guideline updates; leaves open need for RCTs confirming benefits of devices and AI.
This narrative review summarizes recent advancements in heart failure management, highlighting new pharmacological therapies, precision medicine, and AI innovations.
Saheed E. Sanyaolu (2025) conducted a review in Heart failure. Recent advancements in heart failure management, including SGLT-2 inhibitors, novel medical devices, and artificial intelligence, have expanded therapeutic options and improved patient outcomes.